122 related articles for article (PubMed ID: 32134758)
1. Randomized trial of intracoronary adenosine as adjunctive therapy for prevention of the no-reflow phenomenon.
Naghshtabrizi N; Sajedi M; Naghshtabrizi B; Mozayanimonfared A; Ali Seif Rabiei M; Kanonisabet A
Coron Artery Dis; 2020 Sep; 31(6):527-529. PubMed ID: 32134758
[TBL] [Abstract][Full Text] [Related]
2. The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.
Nazir SA; Khan JN; Mahmoud IZ; Greenwood JP; Blackman DJ; Kunadian V; Been M; Abrams KR; Wilcox R; Adgey AA; McCann GP; Gershlick AH
Trials; 2014 Sep; 15():371. PubMed ID: 25252600
[TBL] [Abstract][Full Text] [Related]
3. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
[TBL] [Abstract][Full Text] [Related]
4. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
[TBL] [Abstract][Full Text] [Related]
5. Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.
Peng Y; Fu X; Li W; Geng W; Xing K; Ru L; Sun J; Zhao Y
Coron Artery Dis; 2014 Dec; 25(8):645-52. PubMed ID: 25230304
[TBL] [Abstract][Full Text] [Related]
6. Administration of intracoronary adenosine before stenting for the prevention of no-reflow in patients with ST-elevation myocardial infarction.
Sadeghian M; Mousavi SH; Aamaraee Z; Shafiee A
Scand Cardiovasc J; 2022 Dec; 56(1):23-27. PubMed ID: 35253571
[No Abstract] [Full Text] [Related]
7. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
[TBL] [Abstract][Full Text] [Related]
8. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.
Fokkema ML; Vlaar PJ; Vogelzang M; Gu YL; Kampinga MA; de Smet BJ; Jessurun GA; Anthonio RL; van den Heuvel AF; Tan ES; Zijlstra F
Circ Cardiovasc Interv; 2009 Aug; 2(4):323-9. PubMed ID: 20031735
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning.
Parikh KH; Chag MC; Shah KJ; Shah UG; Baxi HA; Chandarana AH; Naik AM; Shah JN; Shah HD; Goyal RK
Can J Physiol Pharmacol; 2007; 85(3-4):476-82. PubMed ID: 17612657
[TBL] [Abstract][Full Text] [Related]
10. Nicardipine and adenosine "flush cocktail" to prevent no-reflow during rotational atherectomy.
Fischell TA; Haller S; Pulukurthy S; Virk IS
Cardiovasc Revasc Med; 2008; 9(4):224-8. PubMed ID: 18928946
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective effect of high-dose intragraft adenosine infusion on microvascular function and prevention of no-reflow during saphenous vein grafts intervention.
Kapoor N; Yalamanchili V; Siddiqui T; Raza S; Leesar MA
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1045-54. PubMed ID: 24307656
[TBL] [Abstract][Full Text] [Related]
12. Short-term effect of verapamil on coronary no-reflow associated with percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials.
Su Q; Li L; Liu Y
Clin Cardiol; 2013 Aug; 36(8):E11-6. PubMed ID: 23749333
[TBL] [Abstract][Full Text] [Related]
13. Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Akpek M; Sahin O; Sarli B; Baktir AO; Saglam H; Urkmez S; Ergin A; Oguzhan A; Arinc H; Kaya MG
Angiology; 2015 Jul; 66(6):560-7. PubMed ID: 25092681
[TBL] [Abstract][Full Text] [Related]
14. Perforated balloon technique: A simple and handy technique to combat no-reflow phenomenon in coronary system.
Patel T; Shah S; Gulati R; Kwan T; Cohen MG; Pancholy S
Catheter Cardiovasc Interv; 2018 Nov; 92(5):890-894. PubMed ID: 29280545
[TBL] [Abstract][Full Text] [Related]
15. Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction.
Faruk Akturk I; Arif Yalcin A; Biyik I; Sarikamis C; Turhan Caglar N; Erturk M; Celik O; Uzun F; Murat Caglar I; Oner E
Minerva Cardioangiol; 2014 Oct; 62(5):389-97. PubMed ID: 24699550
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
[TBL] [Abstract][Full Text] [Related]
17. Effect of adjunctive intracoronary adenosine on myocardial ischemia, hemodynamic function and left ventricular performance during percutaneous transluminal coronary angioplasty: clinical access to ischemic preconditioning?
Heidland UE; Heintzen MP; Michel CJ; Strauer BE
Coron Artery Dis; 2000 Jul; 11(5):421-8. PubMed ID: 10895409
[TBL] [Abstract][Full Text] [Related]
18. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
[TBL] [Abstract][Full Text] [Related]
19. Treating acute "no-reflow" with intracoronary adenosine in 4 patients during percutaneous coronary intervention.
Forman MB; Hou D; Jackson EK
Tex Heart Inst J; 2008; 35(4):439-46. PubMed ID: 19156238
[TBL] [Abstract][Full Text] [Related]
20. Management of No-Reflow Phenomenon in the Catheterization Laboratory.
Rezkalla SH; Stankowski RV; Hanna J; Kloner RA
JACC Cardiovasc Interv; 2017 Feb; 10(3):215-223. PubMed ID: 28183461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
